Netris Pharma Raises €7.5M; Extends Series A to €24.4M
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Netris Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
The antibody is believed to block a protein in cancer cells and could make chemotherapy more effective
Laboratory findings have set the stage for a clinical trial investigating a drug for pancreatic cancer that has spread to the liver.
Pancreatic cancer is tricky to manage because it spreads easily and early, and the tumors have a unique biological makeup.
<p>A new scientific finding at the University of Rochester is the foundation for the first clinical trial in the U.S. to study an experimental drug's ability to fight pancreatic cancer with metastasis to the liver. The trial is expected to launch early in 2024 at UR's Wilmot Cancer Institute. </p> <p> </p> <p> </p>